AbCellera
is it valuable accelerating approval of an average antibody drug by year could be worth more than in drugging the could unlock billion in new market opportunities being first to market could easily be billions in sales profit and value saving small from reinventing the wheel could be worth more than million eer | AbCellera
Company
Deck date
May 2022
Slide
9 of 25
Related slides by other companies
Start Up
February 2021
Investor Presentation
December 2018
Investor Day
May 2022
SPAC
June 2021
Other recent decks by AbCellera
Investor Presentation
February 2024
Investor Conference
January 2024
Results
November 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io